Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
JD Supra1d
The Illumina Ban and What It Means for Life Science Companies
Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...
Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban
Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.
Morningstar23d
Illumina's Large Installed System Base Should Insulate It Somewhat From New Entrants
which gave Illumina the foundation of its sequencing-by-synthesis chemistry in its sequencing instruments. The company previously aimed to to have similar success with the 2021 acquisition of ...
C&EN11d
Sequencing DNA by converting it into an accordion molecule
Kokoris came up with the idea of solving some of the noise issue of nanopore sequencing by converting DNA into larger ...
What Makes Illumina (ILMN) an Attractive Opportunity?
Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the letter ...
Illumina sees 2025 EPS of $4.50 after China ban, consensus $4.51
Illumina (ILMN) responded to the March 4 notice from the China Ministry of Commerce that the company is not permitted to export sequencing ...
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, has been named for the sixth ...